Your email has been successfully added to our mailing list.

×
0.063157894736842 0.063157894736842 0.063157894736842 -0.0315789473684211 0.00842105263157895 0.0901052631578947 -0.198736842105263 -0.189473684210526
Stock impact report

Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders

APRICUS BIOSCIENCES (APRI) 
Last apricus biosciences earnings: 11/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: apricusbio.com
Company Research Source: GlobeNewswire
Transaction to result in Nasdaq-listed company focused on developing novel products to treat central nervous system diseasesTransaction expected to advance Seelos’ robust, late-stage pipeline of five programs, with near-term clinical and regulatory milestones Ownership split of merged company anticipated to be approximately 86% Seelos shareholders and 14% Apricus shareholdersTerms of the transaction to include a Contingent Value Right (CVR) per share to Apricus shareholders of record for Vitaros assets at the time of closingConference call and webcast to be held today at 8:30 AM U.S. Eastern Time NEW YORK, July 30, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI) announced the signing of a definitive agreement to merge with Seelos Therapeutics, Inc., a privately-held biotechnology company, in an all-stock transaction. The merged company will focus on the development and commercialization of central nervous system (CNS) therapeutics with known mechanisms of action Show less Read more
Impact Snapshot
Event Time:
APRI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for APRI alerts
Opt-in for
APRI alerts

from News Quantified
Opt-in for
APRI alerts

from News Quantified